Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × zimberelimab × Clear all

NCT05632848 2025-07-21

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Phase 2 Completed

Triple Negative Breast Neoplasms